Company Search:
Advanced Search
Sponsored Links
OptiNose Inc Company Snapshot
OptiNose Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares OptiNose Inc with three other companies in this sector in UNITED STATES : Progenics Pharmaceuticals, Inc. (2019 sales of $34.99 million of which 100% was Biopharmaceutical), Chembio Diagnostics, Inc. ($34.46 million of which 100% was Product Sales), and Biofrontera AG (ADR) ($34.95 million of which 100% was Pharmaceuticals).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
OptiNose Inc
  Stock Performance Chart for OptiNose Inc
  Stock Data: Recent Stock Performance:
  Current Price (9/11/2020): 4.36
(Figures in U.S. Dollars)
1 Week 1.2%   13 Weeks -17.7%  
4 Weeks -20.1%   52 Weeks -39.3%  
OptiNose Inc Key Data:
  Ticker: OPTN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 34,631,000
(Year Ending Jan 2020).
Employees: 105
  Currency: U.S. Dollars Market Cap: 200,526,310
  Fiscal Yr Ends: December Shares Outstanding: 45,992,273
  Share Type: Common Closely Held Shares: 20,893,413
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.